Clincosm LogoSign in Get a demo

Overweight

Showing NaN - NaN of 35
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Overweight Trial in United States (LY3305677, Placebo)

Not yet recruiting
  • Obesity
  • Overweight
  • Mesa, Arizona
  • +27 more
Nov 21, 2023

Obesity, Overweight, Knee Pain Chronic Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • +4 more
  • Phoenix, Arizona
  • +168 more
Jul 10, 2023

Obesity, Overweight, Osteo Arthritis Knee Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • +2 more
  • Phoenix, Arizona
  • +67 more
Jul 10, 2023

Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)

Recruiting
  • Type 2 Diabetes
  • +5 more
  • Muscle Shoals, Alabama
  • +320 more
Apr 12, 2023

Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

Not yet recruiting
  • Overweight
  • +2 more
  • Concord, California
  • +147 more
Jan 24, 2023

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Obesity
  • Overweight
  • Gilbert, Arizona
  • +695 more
Jan 18, 2023

Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +804 more
Dec 19, 2022

Overweight, Obesity Trial in Worldwide (Gelesis100, )

Completed
Has Results
  • Overweight
  • Obesity
  • Gelesis100
  • placebo
  • Anaheim, California
  • +35 more
Aug 8, 2022

Pulmonary Disease, Chronic Obstructive, Obesity, Weight Loss Trial in United States (Lifestyle Intervention)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • +4 more
  • Lifestyle Intervention
  • Birmingham, Alabama
  • +38 more
Mar 10, 2022

Overweight, Obesity Trial in Worldwide (NNC0174-0833, Placebo (NNC0174-0833), Liraglutide 3.0 mg)

Completed
  • Overweight
  • Obesity
  • Anaheim, California
  • +53 more
Feb 24, 2022

Overweight, Obesity Trial in United States

Recruiting
  • Overweight
  • Obesity
    • Little Rock, Arkansas
    • +27 more
    Feb 11, 2022

    Overweight Trial in Chicago (CO2, Sham)

    Active, not recruiting
    • Overweight
    • CO2
    • Sham
    • Chicago, Illinois
      Northwestern University
    Jan 4, 2022

    Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide))

    Completed
    Has Results
    • Overweight
    • Obesity
    • Birmingham, Alabama
    • +40 more
    Nov 10, 2021

    Obesity, Overweight Trial in Worldwide (Semaglutide 1.0 mg, Semaglutide 2.4 mg, Placebo I (Semaglutide))

    Completed
    Has Results
    • Obesity
    • Overweight
    • Semaglutide 1.0 mg
    • +3 more
    • Buena Park, California
    • +146 more
    Nov 8, 2021

    Overweight, Healthy Trial in Chicago (Before meal, With Meal, After meal)

    Completed
    • Overweight
    • Healthy
    • Before meal
    • +2 more
    • Chicago, Illinois
      Clinical Nutrition Research Center
    Jul 26, 2021

    Nutritional and Metabolic Disease, Overweight Trial in Chicago (Active Treatment Beverage, Placebo Treatment Beverage)

    Completed
    • Nutritional and Metabolic Disease
    • Overweight
    • Active Treatment Beverage
    • Placebo Treatment Beverage
    • Chicago, Illinois
      Clinical Nutrition Research Center
    Jul 26, 2021

    Overweight, Sleep Trial in Chicago (sleep)

    Completed
    • Overweight
    • Sleep
    • sleep
    • Chicago, Illinois
      University of Chicago
    Feb 3, 2021

    Overweight, Obese, Healthy Trial in Chicago (Coffee, Water)

    Completed
    • Overweight
    • +2 more
    • Coffee
    • Water
    • Chicago, Illinois
      Clinical Nutrition Research Center
    Jan 26, 2021

    Overweight, Healthy Trial in Chicago (3 Placebo Beverages)

    Completed
    • Overweight
    • Healthy
    • 3 Placebo Beverages
    • Chicago, Illinois
      Clinical Nutrition Research Center
    Jan 25, 2021

    Overweight, Obese, Healthy Trial in Chicago (Active Comparator, Placebo Comparator)

    Completed
    • Overweight
    • +2 more
    • Active Comparator
    • Placebo Comparator
    • Chicago, Illinois
      Clinical Nutrition Research Center
    Jan 25, 2021

    Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

    Completed
    Has Results
    • Cardiovascular Disease
    • +4 more
    • Lorcaserin hydrochloride
    • Placebo
    • Alexander City, Alabama
    • +498 more
    Jun 27, 2019

    Overweight Trial in Chicago, London, Toronto (High protein, high fiber dietary supplement, Placebo)

    Completed
    • Overweight
    • High protein, high fiber dietary supplement
    • Placebo
    • Chicago, Illinois
    • +2 more
    Jan 31, 2019

    A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

    Terminated
    • Obesity
    • Overweight
      • Fountain Valley, California
      • +10 more
      Jun 25, 2018

      Diabetes, Hyperglycemia, Obesity Trial in Chicago, Evanston (Standard Lifestyle Advice, Advice Plus Lifestyle Intervention)

      Completed
      Has Results
      • Diabetes Mellitus
      • +10 more
      • Standard Lifestyle Advice
      • Advice Plus Lifestyle Intervention
      • Chicago, Illinois
      • +1 more
      Mar 27, 2018

      Obesity, Overweight Trial in United States (NB32, PBO, Weight Management Program)

      Terminated
      Has Results
      • Obesity
      • Overweight
      • Birmingham, Alabama
      • +223 more
      Feb 24, 2017